Heart experts fear Trump’s FDA is ‘ignoring decades of evidence’ as it authorizes new nicotine pouches

The U.S. Food and Drug Administration (FDA) has authorized four new flavored nicotine pouches, saying they may help adults quit smoking cigarettes or using smokeless tobacco. This includes four different offerings manufactured by Helix Innovations.

According to the FDA, this move is part of an ongoing effort to give Americans more alternatives to traditional cigarettes. Tobacco products exist on a spectrum, the agency believes, and getting more people to switch from combusted tobacco products to non-combusted products may represent a step forward in terms of long-term health. The FDA did emphasize it does not believe these products are “safe.” It also said the pouches are not, despite this authorization, “FDA approved.” 

American Heart Association shares concerns

The American Heart Association (AHA) fears that this decision is a step in the wrong direction.

“The AHA is deeply concerned by the FDA’s decision today to authorize four new flavored on! nicotine pouch products manufactured by Helix Innovations,” the group said in a statement. “Nicotine pouches are already the second most popular tobacco product among youth, and flavored tobacco products have long appealed to kids.”

The AHA noted that these authorizations are part of a pilot program that was “never adequately explained to the public.” For instance, it is unclear how this program is any different from the approval process that was in place before.

Subscribe to Cardiovascular Business News

“By authorizing these flavored nicotine pouch products while leaving key questions about the review process unanswered, the FDA appears to be ignoring decades of evidence that the tobacco industry has used flavored products and other tactics to attract and addict youth to its harmful products,” the group wrote. “The tobacco industry cannot be trusted with the health of our nation’s children. Rather than allowing dangerous products on the market, the FDA should protect children’s health by prohibiting the sale of all flavored tobacco products, including menthol.”

FDA authorized fruit-flavored e-cigarettes in May

Back in May, the FDA authorized the marketing of multiple fruit-flavored e-cigarettes. It was the first time the agency authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems (ENDS), which are commonly referred to as vapes.

The American College of Cardiology (ACC) issued a statement at the time calling the authorization an “unprecedented step” that could undo years of progress.

“The ACC maintains that research has shown a link between e-cigarettes and heart attack and coronary artery disease,” the group wrote. “E-cigarette use and nicotine addiction has also been shown to lead to increased risk of tobacco use, which is the leading cause of preventable disease and death in the U.S.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Subscribe to Cardiovascular Business News

Subscribe to Cardiovascular Business News